- Algernon Pharmaceuticals Inc. has obtained permission to begin human trials of a medicine in South Korea.
- This medicine can protect lungs from the lasting damage that COVID-19 virus can cause.
- Many studies and research reports have confirmed the lung damage that even patients having recovered from coronavirus can suffer from.
Some researchers are working with....
Tags : Algernon, Pharmaceuticals, COVID-19, Ifenprodil,